Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients

M. Kotake, R. Shinohara, K. Kato, N. Hayakawa, R. Hayashi, K. Uchimura, M. Makino, M. Nagata, H. Kakizawa, H. Nakagawa, A. Nagasaka, M. Itoh

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Cu,Zn-superoxide dismutase (SOD) activity in erythrocytes is affected by various diseases, including diabetes mellitus (DM). We investigated changes in the Cu,Zn-SOD activity compared to changes in the Cu,ZN-SOD concentration in erythrocytes obtained from patients with Type 2 (non-insulin-dependent) diabetest mellitus. Cu,Zn-SOD activity in erythrocytes was significantly lower in Type 2 DM patients than in healthy non-diabetic subjects. The activity correlated negatively with HbA(1c), but not with other indicators of metabolic control, such as fasting blood glucose or plasma cholesterol or triglyceride. However, there was no statistically significant difference in erythrocyte concentration of Cu,Zn-SOD between diabetic and control samples. Concentration did not correlate with enzymatic activity or HbA(1c). These findings indicate that the inactivation of Cu,Zn-SOD activity in erythrocytes of Type 2 DM patients by hyperglycaemia may be slow, because there is a negative correlation between the enzyme activities and HbA(1c) levels, but not fasting blood glucose levels. This is consistent with glycosylation of the active site of Cu,Zn-SOD, without any effect of hyperglycaemia on the concentration of Cu,Zn-SOD.

Original languageEnglish
Pages (from-to)668-671
Number of pages4
JournalDiabetic Medicine
Volume15
Issue number8
DOIs
Publication statusPublished - 1998

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients'. Together they form a unique fingerprint.

Cite this